Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?

被引:20
作者
Fantegrossi, William E. [1 ]
机构
[1] Emory Univ, Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA 30322 USA
关键词
MDMA; entactogens; self-administration; interspecies dose scaling; neurotoxicity;
D O I
10.1007/s00213-006-0320-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Many animal models relevant to the persistent effects of drugs of abuse necessitate the application of interspecies dose scaling procedures to approximate drug administration regimens in humans, but drug self-administration procedures differ in that they allow animal subjects to control their own drug intake. Objectives: This report reviews the reinforcing effects of 3,4-methylenedioxymethamphetamine (MDMA), its enantiomers, and several structural analogs in rhesus monkeys, paying particular attention to the pharmacological mechanisms of such reinforcing effects, the development of structure activity relationships among these compounds, the stability of MDMA self-administration behavior over time, and the persistent effects of self-administered MDMA on monoamines. Results: The methylenedioxy amphetamine congeners MDMA, 3, 4-methylenedioxyamphetamine, N-ethyl-3,4-methylenedioxyamphetamine, and N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine function as reinforcers in rhesus monkeys, maintaining self-administration behavior greater than that engendered by contingent saline but less than that engendered by traditional psychostimulants. These findings are remarkable as structurally distinct serotonergic hallucinogen-like drugs do not maintain reliable self-administration in laboratory animals. During prolonged MDMA self-administration, MDMA-maintained responding progressively weakens, and MDMA eventually fails to maintain significant self-administration. The neurochemical correlates of this effect have not yet been identified. Conclusions: Procedures in which MDMA and related compounds are self-administered can be established in rhesus monkeys. These techniques can be used to engender contingent MDMA exposure without resorting to controversial methods of interspecies dose scaling. As such, further application of self-administration methods may provide important new insights into the persistent effects of MDMA on brain and behavior in nonhuman primates.
引用
收藏
页码:471 / 482
页数:12
相关论文
共 99 条
  • [21] Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys
    Fantegrossi, WE
    Woods, JH
    Winger, G
    [J]. BEHAVIOURAL PHARMACOLOGY, 2004, 15 (02): : 149 - 157
  • [22] Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys
    Fantegrossi, WE
    Woolverton, WL
    Kilbourn, M
    Sherman, P
    Yuan, J
    Hatzidimitriou, G
    Ricaurte, GA
    Woods, JH
    Winger, G
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 (07) : 1270 - 1281
  • [23] 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement
    Fantegrossi, WE
    Ullrich, T
    Rice, KC
    Woods, JH
    Winger, G
    [J]. PSYCHOPHARMACOLOGY, 2002, 161 (04) : 356 - 364
  • [24] Ferster CB., 1957, Appleton-Century-Crofts
  • [25] Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment
    Frederick, DL
    Ali, SF
    Gillam, MP
    Gossett, J
    Slikker, W
    Paule, MG
    [J]. NEUROCHEMISTRY OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 1998, 844 : 183 - 190
  • [26] Dopamine transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans
    Gatley, SJ
    Volkow, ND
    Gifford, AN
    Fowler, JS
    Dewey, SL
    Ding, YS
    Logan, J
    [J]. PSYCHOPHARMACOLOGY, 1999, 146 (01) : 93 - 100
  • [27] GLENNON RA, 1982, BIOL PSYCHIAT, V17, P807
  • [29] STIMULUS PROPERTIES OF 1-(3,4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE (MDA) ANALOGS
    GLENNON, RA
    YOUSIF, M
    PATRICK, G
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (03) : 443 - 449
  • [30] GOLDBERG SR, 1976, J PHARMACOL EXP THER, V199, P278